Just because a company invests does not mean it has invented anything novel,” Tahir Amin and Rohit Malpani write in this ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics ...

AbbVie (ABBV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Five high-yield names spanning pharmaceuticals, consumer staples, energy, and ETFs offer income investors compelling yields ...

Johnson & Johnson (NYSE:JNJ) and AbbVie (NYSE:ABBV) both posted Q1 2026 results that beat revenue expectations and prompted raised full-year guidance. JNJ leaned on a diversified pharma plus MedTech ...

With Dividend King imbedded income, VYM uses tech stocks for growth to create an investor favorite strong growth and income combination.

Most investors buy Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) because the fund’s reputation tells them they are buying ...

From Eli Lilly's David Ricks to Pfizer's Albert Bourla, the top five highest paid CEOs made a combined $157.8 million in 2025 ...

Schwab U.S. Dividend Equity ETF (SCHD) yields 3.3% with a safe, durable distribution backed by 100 mature dividend payers. SCHD’s top holdings—Bristol Myers Squibb, Lockheed Martin, Chevron, Coca-Cola ...

Abbvie announced an update on their ongoing clinical study. Memorial Day Sale – Claim 70% Off TipRanks. Unlock trusted, data-backed investing tools with TipRanks Premium, from a ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

The ETHIC Act is an important first step for pruning patent thickets and curbing the endless litigation that keeps lower-cost drugs off the shelf.